awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35584746-D192F565-2D26-4A40-BC79-1F6A07A1D12E
Q35584746-D192F565-2D26-4A40-BC79-1F6A07A1D12E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35584746-D192F565-2D26-4A40-BC79-1F6A07A1D12E
Cardiovascular toxicity profiles of vascular-disrupting agents.
P2860
Q35584746-D192F565-2D26-4A40-BC79-1F6A07A1D12E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35584746-D192F565-2D26-4A40-BC79-1F6A07A1D12E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b0089a6e1240909453af5bc35a4171bf6567b91a
P2860
Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results.